Filed: 8/14/2023ACC: 0001104659-23-091377
📋 What this filing means
NEXTECH INVEST LTD. filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $294.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$294.20M
Total AUM (reported)
34.35M
Total Shares
Allocation by class
COM$293.17M99.6%
COM STK$1.03M0.4%
Portfolio Concentration
Top 3$205.61M69.9%
4–10$82.12M27.9%
11–25$6.48M2.2%
Top 3 weight
69.9%
Top 10 weight
97.8%
Voting Authority Distribution
Total shares with voting rights: 34.35M
Sole
Full voting authority
34.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
REVOLUTION MEDICINES INC
SOLEShares4.84M
TypeSH
Market value$129.46M
44.00%
Sole
4.84M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.52M
TypeSH
Market value$42.89M
14.58%
Sole
2.52M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares4.29M
TypeSH
Market value$33.26M
11.30%
Sole
4.29M
Shared
0.00
None
0.00
EQRX INC
SOLEShares13.10M
TypeSH
Market value$24.37M
8.28%
Sole
13.10M
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
SOLEShares1.22M
TypeSH
Market value$13.14M
4.47%
Sole
1.22M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares1.91M
TypeSH
Market value$12.80M
4.35%
Sole
1.91M
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares948.66K
TypeSH
Market value$11.92M
4.05%
Sole
948.66K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares287.25K
TypeSH
Market value$7.13M
2.42%
Sole
287.25K
Shared
0.00
None
0.00
KINNATE BIOPHARMA INC
SOLEShares2.33M
TypeSH
Market value$7.06M
2.40%
Sole
2.33M
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares611.31K
TypeSH
Market value$5.70M
1.94%
Sole
611.31K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares471.28K
TypeSH
Market value$2.95M
1.00%
Sole
471.28K
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.45M
TypeSH
Market value$2.50M
0.85%
Sole
1.45M
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares375.86K
TypeSH
Market value$1.03M
0.35%
Sole
375.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 4.84M | SH | $129.46M 44.00% | 4.84M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 2.52M | SH | $42.89M 14.58% | 2.52M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 4.29M | SH | $33.26M 11.30% | 4.29M | 0.00 | 0.00 |
EQRX INCSOLE | COM | 13.10M | SH | $24.37M 8.28% | 13.10M | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCSOLE | COM | 1.22M | SH | $13.14M 4.47% | 1.22M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 1.91M | SH | $12.80M 4.35% | 1.91M | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 948.66K | SH | $11.92M 4.05% | 948.66K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 287.25K | SH | $7.13M 2.42% | 287.25K | 0.00 | 0.00 |
KINNATE BIOPHARMA INCSOLE | COM | 2.33M | SH | $7.06M 2.40% | 2.33M | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 611.31K | SH | $5.70M 1.94% | 611.31K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 471.28K | SH | $2.95M 1.00% | 471.28K | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.45M | SH | $2.50M 0.85% | 1.45M | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 375.86K | SH | $1.03M 0.35% | 375.86K | 0.00 | 0.00 |